Bolin Richard

Manager, Partnership Development Group, National B
Molecular Biology
National Renewable Energy Laboratory
United States of America

Academician Molecular Biology
Biography

MBA, Marketing and Organization Management, Leeds School of Business, University of Colorado at Boulder, M.S., Molecular Biology, George Mason University, B.S., Biology, Virginia Polytechnic Institute and State University.Manager, Partnership Development Group, National Renewable Energy Laboratory, National Bioenergy Center (NBC), 2013–present, Senior Project Manager, Partnership Development Group, NBC, 2009–present, Acting Director/Commercialization Manager/ Market Analyst, NREL Technology Transfer Office, 2000–2009, Principal Consultant, 1998–2000,Senior Research Associate, Research and Development, Gilead Pharmaceuticals (formerly NexStar Pharmaceuticals), 1992–1998

Research Intrest

biomass and biosciences 

List of Publications
Drolet DW, Nelson J, Tucker CE, Zack PM, Nixon K, Bolin R, Judkins MB, Farmer JA, Wolf JL, Gill SC, Bendele RA. Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharmaceutical research. 2000 Dec 1;17(12):1503-10.
Guirakhoo F, Bolin RA, Roehrig JT. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology. 1992 Dec 1;191(2):921-31.
Roehrig JT, Bolin RA, Kelly RG. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology. 1998 Jul 5;246(2):317-28.